Rafael Blesa

19.4k total citations
155 papers, 6.3k citations indexed

About

Rafael Blesa is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Rafael Blesa has authored 155 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Physiology, 55 papers in Psychiatry and Mental health and 43 papers in Neurology. Recurrent topics in Rafael Blesa's work include Alzheimer's disease research and treatments (63 papers), Dementia and Cognitive Impairment Research (54 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Rafael Blesa is often cited by papers focused on Alzheimer's disease research and treatments (63 papers), Dementia and Cognitive Impairment Research (54 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Rafael Blesa collaborates with scholars based in Spain, United States and United Kingdom. Rafael Blesa's co-authors include Alberto Lleó, Jordi Clarimón, Juan Fortea, Daniel Alcolea, José Luís Molinuevo, Jordi Peña‐Casanova, Rafael Oliva, J. M. Sol, Pilar Santacruz and María Carmona‐Iragui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Rafael Blesa

152 papers receiving 6.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rafael Blesa 2.5k 2.1k 1.9k 1.1k 999 155 6.3k
Howard Crystal 3.2k 1.3× 3.0k 1.5× 1.2k 0.7× 1.1k 1.1× 826 0.8× 71 6.9k
Mario Masellis 1.2k 0.5× 1.9k 0.9× 1.5k 0.8× 1.0k 0.9× 916 0.9× 184 6.6k
Ruben Smith 4.0k 1.6× 3.1k 1.5× 1.0k 0.5× 1.3k 1.2× 1.4k 1.4× 151 7.2k
Alexander Kurz 2.3k 0.9× 1.9k 0.9× 1.1k 0.6× 669 0.6× 896 0.9× 99 4.8k
Jon B. Toledo 3.6k 1.4× 2.3k 1.1× 3.3k 1.7× 927 0.9× 1.7k 1.7× 104 8.2k
Steven D. Edland 3.0k 1.2× 3.6k 1.7× 836 0.4× 988 0.9× 1.3k 1.3× 156 7.5k
Joseph J. Locascio 2.4k 1.0× 2.4k 1.1× 2.2k 1.2× 1.4k 1.3× 670 0.7× 72 5.9k
L Berg 4.1k 1.6× 3.7k 1.8× 1.2k 0.7× 1.1k 1.0× 1.3k 1.3× 12 7.1k
Robert Perry 1.3k 0.5× 1.2k 0.6× 1.2k 0.7× 543 0.5× 1.3k 1.3× 75 4.8k
Juan Fortea 2.3k 0.9× 1.6k 0.8× 956 0.5× 674 0.6× 1.0k 1.0× 205 5.0k

Countries citing papers authored by Rafael Blesa

Since Specialization
Citations

This map shows the geographic impact of Rafael Blesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Blesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Blesa more than expected).

Fields of papers citing papers by Rafael Blesa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Blesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Blesa. The network helps show where Rafael Blesa may publish in the future.

Co-authorship network of co-authors of Rafael Blesa

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Blesa. A scholar is included among the top collaborators of Rafael Blesa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Blesa. Rafael Blesa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sirisi, Sònia, Marta Querol‐Vilaseca, Oriol Dols‐Icardo, et al.. (2022). Myelin loss in C9orf72 hexanucleotide expansion carriers. Journal of Neuroscience Research. 100(10). 1862–1875. 4 indexed citations
2.
Pegueroles, Jordi, Víctor Montal, Alexandre Bejanin, et al.. (2021). AMYQ: An index to standardize quantitative amyloid load across PET tracers. Alzheimer s & Dementia. 17(9). 1499–1508. 14 indexed citations
3.
Montal, Víctor, Isabel Barroeta, Alexandre Bejanin, et al.. (2021). Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. Annals of Neurology. 90(3). 407–416. 10 indexed citations
4.
Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations
5.
Benejam, Bessy, Laura Videla, Eduard Vilaplana, et al.. (2020). Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12047–e12047. 31 indexed citations
6.
Gonzalo‐Calvo, David de, Isabel Barroeta, María Carmona‐Iragui, et al.. (2020). Evaluation of biochemical and hematological parameters in adults with Down syndrome. Scientific Reports. 10(1). 13755–13755. 3 indexed citations
7.
Alcolea, Daniel, Jordi Pegueroles, Laia Muñoz, et al.. (2019). Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse. Annals of Clinical and Translational Neurology. 6(9). 1815–1824. 98 indexed citations
8.
Alcolea, Daniel, Eduard Vilaplana, Marc Suárez‐Calvet, et al.. (2017). CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 89(2). 178–188. 92 indexed citations
9.
Brás, José, Ruth Djaldetti, Simon Mead, et al.. (2016). Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation. Neurobiology of Aging. 46. 236.e1–236.e6. 18 indexed citations
10.
Cummings, Jeffrey L., Philip Scheltens, Ian G. McKeith, et al.. (2016). Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 55(3). 1131–1139. 29 indexed citations
11.
Querol, Luís, Gisela Nogales‐Gadea, Ricardo Rojas‐García, et al.. (2014). Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 82(10). 879–886. 276 indexed citations
12.
Scheltens, Philip, Jos W. R. Twisk, Rafael Blesa, et al.. (2012). Souvenaid (R) Improves Memory in Drug-Naive Patients with Mild Alzheimer's Disease: Results from a Randomized, Controlled, Double-Blind Study (Souvenir II). Pure Amsterdam UMC. 3 indexed citations
13.
Scheltens, Philip, Jos W. R. Twisk, Rafael Blesa, et al.. (2012). Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial. Journal of Alzheimer s Disease. 31(1). 225–236. 211 indexed citations
14.
Fortea, Juan, Albert Lladó, Jordi Clarimón, et al.. (2011). PICOGEN: Five years experience with a genetic counselling program for dementia. SHILAP Revista de lepidopterología. 26(3). 143–149. 18 indexed citations
15.
Calero, Olga, María J. Bullido, Jordi Clarimón, et al.. (2011). Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases. PLoS ONE. 6(7). e22090–e22090. 32 indexed citations
16.
Emre, Murat, Roberto Bernabei, Rafael Blesa, et al.. (2010). Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease. CNS Neuroscience & Therapeutics. 16(4). 246–253. 27 indexed citations
17.
Fortea, Juan, Albert Lladó, Jordi Clarimón, et al.. (2010). PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia. Neurología. 26(3). 143–149. 24 indexed citations
18.
Guarch, Joana, T. Marcos, Manel Salamero, Cristòbal Gastó, & Rafael Blesa. (2007). Mild cognitive impairment: a risk indicator of later dementia, or a preclinical phase of the disease?. International Journal of Geriatric Psychiatry. 23(3). 257–265. 33 indexed citations
19.
Yebra, Lluı̈sa de, et al.. (2004). Reduced KIAA0471 mRNA expression in Alzheimer's patients: a new candidate gene product linked to the disease?. Human Molecular Genetics. 13(21). 2607–2612. 5 indexed citations
20.
Casademont, Jordi, et al.. (2002). Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease. Journal of the Neurological Sciences. 206(1). 23–26. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard Crystal Breakdown of academic impact, for papers by Mario Masellis Breakdown of academic impact, for papers by Ruben Smith Breakdown of academic impact, for papers by Alexander Kurz Breakdown of academic impact, for papers by Jon B. Toledo Breakdown of academic impact, for papers by Steven D. Edland Breakdown of academic impact, for papers by Joseph J. Locascio Breakdown of academic impact, for papers by L Berg Breakdown of academic impact, for papers by Robert Perry Breakdown of academic impact, for papers by Juan Fortea
Rankless by CCL
2026